Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n- propylamino)tetralin in awake cats

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 229-238

  Fornal, Casimir A ^a   Martin, Francisco J ^a,b   Metzler, Christine W ^a   Jacobs, Barry L ^a  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TERTATOLOL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; DEPRESSION; DOSE RESPONSE; DRUG MECHANISM; INHIBITION KINETICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEROTONIN RELEASE; SINGLE UNIT ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CATS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; NEURONS; PINDOLOL; PROPANOLAMINES; RAPHE NUCLEI; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; THIOPHENES;

EID: 0032872019     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Aghajanian GK and VanderMaelen CP (1986) Specific systems of the reticular core: Serotonin. Handb Physiol 4:237-256.
2. 1A antagonists. Trends Neurosci 19:378-383.
3. 1B receptors. Neuropharmacology 35:213-222.
4. Aulakh CS, Wozniak KM, Haas M, Hill JL, Zohar J and Murphy DL (1988) Food intake, neuroendocrine and temperature effects of 8-OH-DPAT in the rat. Eur J Pharmacol 146:253-259.
5. Blier P and Bergeron R (1998) The use of pindolol to potentiate antidepressant medication. J Clin Psychiatry 59 (Suppl 5):16-23.
6. Blier P, Steinberg S, Chaput Y and de Montigny C (1989) Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: A single-cell study in the rat dorsal raphe nucleus. Can J Physiol Pharmacol 67:98-105.
7. 1A autoreceptors and increases dorsal raphe unit activity in awake cats. Eur J Pharmacol 356:167-178.
8. Bosker FJ, Donker MG, Klompmakers AA, Kurata K and Westenberg HGM (1994) 5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: Modulation by pindolol. Prog Neuropsychopharmacol Biol Psychiatry 18:765-778.
9. Burden DT and Hamilton TC (1976) Hypotensive responses following oral administration of β-adrenoceptor blocking drugs to the conscious cat. Eur J Pharmacol 38:55-61.
10. Clark BJ, Menninger K and Bertholet A (1982) Pindolol - The pharmacology of a partial agonist. Br J Clin Pharmacol 13:149S-158S.
11. 1A autoreceptor in vivo. Br J Pharmacol 124:206-212.
12. 1A receptors in the rat brain. Br J Pharmacol 123:449-462.
13. 1A agonists. Synapse 14:297-304.
14. 1A receptors. Neurochem Res 21:557-562.
15. 1A receptor antagonist. Behav Brain Res 73:337-353.
16. Fornal CA and Jacobs BL (1988) Physiological and behavioral correlates of serotonergic single-unit activity, in Neuronal Serotonin (Osborne NN and Hamon M eds) pp 305-345, John Wiley & Sons, Inc., New York.
17. Fornal CA, Litto WJ, Morilak DA and Jacobs BL (1990) Single-unit responses of serotonergic neurons to vasoactive drug administration in behaving cats. Am J Physiol 259:R963-R972.
18. 1A antagonists BMY 7378, NAN-190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats. J Pharmacol Exp Ther 270:1359-1366.
19. 1A receptor antagonist, increases serotonergic neuronal activity in behaving cats: Comparison with (S)-WAY-100135. J Pharmacol Exp Ther 278:752-762.
20. Fornal CA, Martín FJ, Mendlin A, Metzler CW, Bjorvatn B and Jacobs BL (1999a) Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity. Eur J Pharmacol 377:187-191.
21. 1A antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: Comparison to WAY-100635. J Pharmacol Exp Ther 291:220-228.
22. 1A antagonists, (±)-pindolol, (-)-tertatolol and (-)-penbutolol, on extracellular 5-HT in the rat cortex. Br J Pharmacol 123:232P.
23. 1A autoreceptors and noradrenergic mechanisms. Psychopharmacology 130:261-268.
24. Haddjeri N, de Montigny C and Blier P (1998) Modulation of the firing activity of rat dorsal raphe 5-HT neurons and locus coeruleus NA neurons by (±)-pindolol (Abstract). Soc Neurosci Abstr 24:1366.
25. Hjorth S and Carlsson A (1986) Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol 129:131-138.
26. 1A receptors in the rat brain. Naunyn-Schmiedebergs Arch Pharmacol 347:453-463.
27. 1A receptors in vivo. Eur J Pharmacol 240:307-310.
28. 1A agonists. Mol Pharmacol 37:231-237.
29. Meltzer HY and Maes M (1996) Effect of pindolol on hormone secretion and body temperature: Partial agonist effects. J Neural Transm 103:77-88.
30. Middlemiss DN, Neill J and Tricklebank MD (1985) Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading induced by 8-OH-DPAT. Br J Pharmacol 85:251P.
31. 1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites, respectively. Eur J Pharmacol 230:99-102.
32. 1A) receptors. Neuropsychopharmacology 18:395-398.
33. 1B/1D receptors on the modulation of acute fluoxetine-induced changes in 5-HT: The mechanism of action of (±)-pindolol (Abstract). Soc Neurosci Abstr 24:1109.
34. 1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers. Biochem Pharmacol 37:3429-3433.
35. Pierce PA and Peroutka SJ (1989) Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97:118-122.
36. 1A) receptor antagonist in rat brain. J Pharmacol Exp Ther 265:739-744.
37. Rigdon GC and Wang CM (1991) Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Dev Res 22:135-140.
38. 1A receptors: In vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15:349-360.
39. 1A receptor ligands by means of in vivo animal models. Eur J Pharmacol 315:245-254.
40. Schwarz HJ (1982) Pharmacokinetics of pindolol in humans and several animal species. Am Heart J 104:357-364.
41. Sharp T, Bramwell SR, Hjorth S and Grahame-Smith DG (1989) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br J Pharmacol 98:989-997.
42. 1A agonist activity of pindolol: Reversal of the inhibitory effects on cell firing in the dorsal raphe nucleus but not in the hippocampus by WAY-100,635. Ann NY Acad Sci 861:274-275.
43. 1A receptor. Eur J Pharmacol 133:47-56.
44. Winter JC and Rabin RA (1993) Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin. Pharmacol Biochem Behav 44:851-855.